{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:26:03Z","timestamp":1762169163359,"version":"build-2065373602"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023T160439"],"award-info":[{"award-number":["2023T160439"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82422027, U24A20340","82327809, 82020108013"],"award-info":[{"award-number":["82422027, U24A20340","82327809, 82020108013"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Basic and Applied Basic Science Foundation for Distinguished Young Scholars","award":["2023B1515020113"],"award-info":[{"award-number":["2023B1515020113"]}]},{"name":"STI2030-Major Projects","award":["2022ZD0211800"],"award-info":[{"award-number":["2022ZD0211800"]}]},{"name":"the Construction Fund of Key Medical Disciplines of Hangzhou, Qiantang Scholars Program and Tianchi Scholars Program"},{"name":"Open Research Fund of the State Key Laboratory of Cognitive Neuroscience and Learning","award":["CNLZD2101, CNLZD2303"],"award-info":[{"award-number":["CNLZD2101, CNLZD2303"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-025-01882-9","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:08:35Z","timestamp":1762168115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal characteristics of plasma biomarkers in Chinese older adults with Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"17","author":[{"given":"Ruixian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingkai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhe","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengfei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"5054","key":"1882_CR1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"8","key":"1882_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.biopsych.2020.06.029","volume":"89","author":"T Guo","year":"2021","unstructured":"Guo T, Korman D, Baker SL, Landau SM, Jagust WJ. Longitudinal cognitive and biomarker measurements support a unidirectional pathway in alzheimer\u2019s disease pathophysiology. Biol Psychiatry. 2021;89(8):786\u201394.","journal-title":"Biol Psychiatry"},{"issue":"23","key":"1882_CR3","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1001\/jama.2019.7437","volume":"321","author":"CR Jack Jr","year":"2019","unstructured":"Jack CR Jr., Wiste HJ, Therneau TM, et al. Associations of Amyloid, Tau, and neurodegeneration biomarker profiles with rates of memory decline among individuals without dementia. JAMA. 2019;321(23):2316\u201325.","journal-title":"JAMA"},{"issue":"22","key":"1882_CR4","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1016\/j.cell.2023.09.023","volume":"186","author":"AL Boxer","year":"2023","unstructured":"Boxer AL, Sperling R. Accelerating alzheimer\u2019s therapeutic development: the past and future of clinical trials. Cell. 2023;186(22):4757\u201372.","journal-title":"Cell"},{"issue":"6","key":"1882_CR5","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nn.4017","volume":"18","author":"K Herrup","year":"2015","unstructured":"Herrup K. The case for rejecting the amyloid cascade hypothesis. Nat Neurosci. 2015;18(6):794\u20139.","journal-title":"Nat Neurosci"},{"issue":"4","key":"1882_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr., Bennett DA, Blennow K, et al. NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"1882_CR7","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1002\/alz.13084","volume":"19","author":"BP Imbimbo","year":"2023","unstructured":"Imbimbo BP, Watling M, Imbimbo C, Nistic\u00f2 R. Plasma ATN(I) classification and precision Pharmacology in alzheimer\u2019s disease. Alzheimers Dement. 2023;19(10):4729\u201334.","journal-title":"Alzheimers Dement"},{"key":"1882_CR8","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","volume":"10","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N. Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol. 2019;10:1008.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1882_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P. Neuroinflammation and microglial activation in alzheimer disease: where do we go from here? Nat Rev Neurol. 2021;17(3):157\u201372.","journal-title":"Nat Rev Neurol"},{"issue":"1\u20132","key":"1882_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.brainresrev.2009.11.004","volume":"63","author":"MT Heneka","year":"2010","unstructured":"Heneka MT, Rodr\u00edguez JJ, Verkhratsky A. Neuroglia in neurodegeneration. Brain Res Rev. 2010;63(1\u20132):189\u2013211.","journal-title":"Brain Res Rev"},{"issue":"1","key":"1882_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s13024-024-00750-8","volume":"19","author":"T Guo","year":"2024","unstructured":"Guo T, Li A, Sun P, et al. Astrocyte reactivity is associated with Tau tangle load and cortical thinning in alzheimer\u2019s disease. Mol Neurodegener. 2024;19(1):58.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"1882_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"1882_CR13","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, et al. Donanemab in early symptomatic alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512\u201327.","journal-title":"JAMA"},{"issue":"2","key":"1882_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.molmed.2018.11.006","volume":"25","author":"SF Carter","year":"2019","unstructured":"Carter SF, Herholz K, Rosa-Neto P, Pellerin L, Nordberg A, Zimmer ER. Astrocyte biomarkers in alzheimer\u2019s disease. Trends Mol Med. 2019;25(2):77\u201395.","journal-title":"Trends Mol Med"},{"key":"1882_CR15","doi-asserted-by":"crossref","unstructured":"Jack CR Jr., Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20(8):5143\u201369.","DOI":"10.1002\/alz.13859"},{"issue":"6","key":"1882_CR16","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois B, Villain N, Frisoni GB, et al. Clinical diagnosis of alzheimer\u2019s disease: recommendations of the international working group. Lancet Neurol. 2021;20(6):484\u201396.","journal-title":"Lancet Neurol"},{"issue":"6","key":"1882_CR17","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41591-021-01382-x","volume":"27","author":"O Hansson","year":"2021","unstructured":"Hansson O. Biomarkers for neurodegenerative diseases. Nat Med. 2021;27(6):954\u201363.","journal-title":"Nat Med"},{"issue":"7","key":"1882_CR18","doi-asserted-by":"publisher","first-page":"e688","DOI":"10.1212\/WNL.0000000000013211","volume":"98","author":"Y Li","year":"2022","unstructured":"Li Y, Schindler SE, Bollinger JG, et al. Validation of plasma amyloid-\u03b2 42\/40 for detecting alzheimer disease amyloid plaques. Neurology. 2022;98(7):e688\u201399.","journal-title":"Neurology"},{"issue":"17","key":"1882_CR19","doi-asserted-by":"publisher","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","volume":"93","author":"SE Schindler","year":"2019","unstructured":"Schindler SE, Bollinger JG, Ovod V, et al. High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis. Neurology. 2019;93(17):e1647\u201359.","journal-title":"Neurology"},{"issue":"12","key":"1882_CR20","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1002\/alz.12613","volume":"18","author":"O Hanon","year":"2022","unstructured":"Hanon O, Vidal JS, Lehmann S, et al. Plasma amyloid beta predicts conversion to dementia in subjects with mild cognitive impairment: the BALTAZAR study. Alzheimers Dement. 2022;18(12):2537\u201350.","journal-title":"Alzheimers Dement"},{"key":"1882_CR21","doi-asserted-by":"crossref","unstructured":"Sun P, He Z, Li A et al. Spatial and temporal patterns of cortical mean diffusivity in Alzheimer\u2019s disease and suspected non-Alzheimer\u2019s disease pathophysiology. Alzheimers Dement. 2024;20(10):7048\u201361.","DOI":"10.1002\/alz.14176"},{"issue":"1","key":"1882_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13195-023-01174-0","volume":"15","author":"Y Guo","year":"2023","unstructured":"Guo Y, Shen XN, Wang HF, et al. The dynamics of plasma biomarkers across the alzheimer\u2019s continuum. Alzheimers Res Ther. 2023;15(1):31.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"1882_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/alz.12614","volume":"19","author":"H Stocker","year":"2023","unstructured":"Stocker H, Beyer L, Perna L, et al. Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical alzheimer\u2019s disease risk: results from a prospective cohort followed over 17 years. Alzheimers Dement. 2023;19(1):25\u201335.","journal-title":"Alzheimers Dement"},{"key":"1882_CR24","doi-asserted-by":"publisher","first-page":"106356","DOI":"10.1016\/j.nbd.2023.106356","volume":"189","author":"AL Wojda\u0142a","year":"2023","unstructured":"Wojda\u0142a AL, Bellomo G, Gaetani L, et al. Trajectories of CSF and plasma biomarkers across alzheimer\u2019s disease continuum: disease staging by NF-L, p-tau181, and GFAP. Neurobiol Dis. 2023;189:106356.","journal-title":"Neurobiol Dis"},{"issue":"7","key":"1882_CR25","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41591-023-02380-x","volume":"29","author":"B Bellaver","year":"2023","unstructured":"Bellaver B, Povala G, Ferreira PCL, et al. Astrocyte reactivity influences amyloid-\u03b2 effects on Tau pathology in preclinical alzheimer\u2019s disease. Nat Med. 2023;29(7):1775\u201381.","journal-title":"Nat Med"},{"issue":"10","key":"1882_CR26","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1002\/alz.13157","volume":"19","author":"M Bilgel","year":"2023","unstructured":"Bilgel M, An Y, Walker KA, et al. Longitudinal changes in Alzheimer\u2019s-related plasma biomarkers and brain amyloid. Alzheimers Dement. 2023;19(10):4335\u201345.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"1882_CR27","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1002\/alz.13318","volume":"19","author":"Y Yakoub","year":"2023","unstructured":"Yakoub Y, Ashton NJ, Strikwerda-Brown C, et al. Longitudinal blood biomarker trajectories in preclinical alzheimer\u2019s disease. Alzheimers Dement. 2023;19(12):5620\u201331.","journal-title":"Alzheimers Dement"},{"issue":"7","key":"1882_CR28","doi-asserted-by":"publisher","first-page":"e028188","DOI":"10.1136\/bmjopen-2018-028188","volume":"9","author":"X Li","year":"2019","unstructured":"Li X, Wang X, Su L, Hu X, Han Y. Sino longitudinal study on cognitive decline (SILCODE): protocol for a Chinese longitudinal observational study to develop risk prediction models of conversion to mild cognitive impairment in individuals with subjective cognitive decline. BMJ Open. 2019;9(7):e028188.","journal-title":"BMJ Open"},{"key":"1882_CR29","doi-asserted-by":"crossref","unstructured":"Li A, Zhao R, Zhang M, et al. [(18)F]-D3FSP \u03b2-amyloid PET imaging in older adults and alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging. 2024;51(13):3990\u20134000.","DOI":"10.1007\/s00259-024-06835-2"},{"issue":"4","key":"1882_CR30","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2967\/jnumed.114.148981","volume":"56","author":"SM Landau","year":"2015","unstructured":"Landau SM, Fero A, Baker SL, et al. Measurement of longitudinal \u03b2-amyloid change with 18F-florbetapir PET and standardized uptake value ratios. J Nucl Med. 2015;56(4):567\u201374.","journal-title":"J Nucl Med"},{"issue":"4","key":"1882_CR31","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/alz.12724","volume":"19","author":"P Chatterjee","year":"2023","unstructured":"Chatterjee P, Pedrini S, Doecke JD, et al. Plasma A\u03b242\/40 ratio, p-tau181, GFAP, and NfL across the alzheimer\u2019s disease continuum: A cross-sectional and longitudinal study in the AIBL cohort. Alzheimers Dement. 2023;19(4):1117\u201334.","journal-title":"Alzheimers Dement"},{"key":"1882_CR32","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2147\/CIA.S357994","volume":"17","author":"J Wang","year":"2022","unstructured":"Wang J, Gao L, Liu J, et al. The association of plasma Amyloid-\u03b2 and cognitive decline in cognitively unimpaired population. Clin Interv Aging. 2022;17:555\u201365.","journal-title":"Clin Interv Aging"},{"issue":"4","key":"1882_CR33","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1002\/alz.12801","volume":"19","author":"C Rabe","year":"2023","unstructured":"Rabe C, Bittner T, Jethwa A, et al. Clinical performance and robustness evaluation of plasma amyloid-\u03b2(42\/40) Prescreening. Alzheimers Dement. 2023;19(4):1393\u2013402.","journal-title":"Alzheimers Dement"},{"issue":"16","key":"1882_CR34","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.scib.2023.07.009","volume":"68","author":"F Gao","year":"2023","unstructured":"Gao F, Dai L, Wang Q, et al. Blood-based biomarkers for alzheimer\u2019s disease: a multicenter-based cross-sectional and longitudinal study in China. Sci Bull (Beijing). 2023;68(16):1800\u20138.","journal-title":"Sci Bull (Beijing)"},{"issue":"6","key":"1882_CR35","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1002\/alz.13829","volume":"20","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Ferreira PCL, Jacobsen E, et al. Association of plasma biomarkers of alzheimer\u2019s disease and related disorders with cognition and cognitive decline: the MYHAT population-based study. Alzheimers Dement. 2024;20(6):4199\u2013211.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1882_CR36","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/brain\/awac399","volume":"146","author":"C Johansson","year":"2023","unstructured":"Johansson C, Thordardottir S, Laffita-Mesa J, et al. Plasma biomarker profiles in autosomal dominant alzheimer\u2019s disease. Brain. 2023;146(3):1132\u201340.","journal-title":"Brain"},{"issue":"12","key":"1882_CR37","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet AL, Mil\u00e0-Alom\u00e0 M, Vrillon A, et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the alzheimer disease continuum. JAMA Neurol. 2021;78(12):1471\u201383.","journal-title":"JAMA Neurol"},{"key":"1882_CR38","doi-asserted-by":"publisher","first-page":"g4287","DOI":"10.1136\/bmj.g4287","volume":"349","author":"P Sedgwick","year":"2014","unstructured":"Sedgwick P. Pitfalls of statistical hypothesis testing: type I and type II errors. BMJ. 2014;349:g4287.","journal-title":"BMJ"},{"issue":"6","key":"1882_CR39","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/s41582-024-00962-y","volume":"20","author":"SJB Vos","year":"2024","unstructured":"Vos SJB, Delvenne A, Jack CR Jr., Thal DR, Visser PJ. The clinical importance of suspected non-Alzheimer disease pathophysiology. Nat Rev Neurol. 2024;20(6):337\u201346.","journal-title":"Nat Rev Neurol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01882-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-025-01882-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-025-01882-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:08:38Z","timestamp":1762168118000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-025-01882-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1882"],"URL":"https:\/\/doi.org\/10.1186\/s13195-025-01882-9","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SILCODE study was approved by the Medical Ethics Committee of Xuanwu Hospital, Capital Medical University, according to the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants, and the publication of clinical details was authorized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}